脓皮病患者从阿达木单抗转用certolizumab pegol生物制剂可能产生的疗效。

{"title":"脓皮病患者从阿达木单抗转用certolizumab pegol生物制剂可能产生的疗效。","authors":"Minoru Kimura, Akihiko Uchiyama, Yukie Endo, Masahito Yasuda, Sei-ichiro Motegi","doi":"10.1111/1346-8138.17429","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":54848,"journal":{"name":"Journal of Dermatology","volume":"52 2","pages":"e153-e154"},"PeriodicalIF":2.3000,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Possible effectiveness of switching biologics from adalimumab to certolizumab pegol in pyoderma gangrenosum\",\"authors\":\"Minoru Kimura, Akihiko Uchiyama, Yukie Endo, Masahito Yasuda, Sei-ichiro Motegi\",\"doi\":\"10.1111/1346-8138.17429\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":54848,\"journal\":{\"name\":\"Journal of Dermatology\",\"volume\":\"52 2\",\"pages\":\"e153-e154\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2024-08-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Dermatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.17429\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Dermatology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.17429","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}